Extrapolation of the TGF-β pathological roles in other types of ILD and fibrosis, specifically IPF, allows researchers to identify specific regulatory molecules of this pathway in CTD-ILDs where current evidence is limited. Here, TGFB1 is linked to interstitial lung disease.